Herpes gestationis, third trimester
ICD-10 O26.43 is a billable code used to indicate a diagnosis of herpes gestationis, third trimester.
Herpes gestationis, also known as pemphigoid gestationis, is an autoimmune blistering skin condition that typically arises during the second or third trimester of pregnancy. It is characterized by the appearance of itchy, blistering lesions that can occur on the abdomen, thighs, and buttocks. The condition is thought to be related to the body's immune response to placental antigens. While herpes gestationis is not harmful to the fetus, it can cause significant discomfort for the mother and may lead to complications such as preterm birth if left untreated. Management often involves the use of topical corticosteroids and antihistamines to alleviate symptoms. Close monitoring is essential, especially in the third trimester, to ensure maternal and fetal well-being. The condition usually resolves after delivery, but it can recur in subsequent pregnancies. Accurate coding is crucial for proper management and tracking of this condition in obstetric care.
Detailed notes on the onset, duration, and severity of symptoms, as well as treatment plans and responses.
A pregnant patient presenting with severe itching and blistering lesions during the third trimester.
Consideration of the patient's obstetric history, including previous occurrences of herpes gestationis.
Comprehensive assessment of maternal and fetal health, including ultrasound findings and fetal monitoring.
Management of a high-risk pregnancy where herpes gestationis is present alongside other complications.
Close monitoring for potential preterm labor or fetal distress.
Used for follow-up visits for management of herpes gestationis during pregnancy.
Document the patient's symptoms, treatment plan, and any changes in condition.
Obstetricians should ensure that all relevant obstetric history is included in the visit notes.
The primary treatment for herpes gestationis includes the use of topical corticosteroids to reduce inflammation and itching. In more severe cases, systemic corticosteroids may be necessary. It is important to monitor the condition closely, especially in the third trimester, to ensure maternal and fetal health.
